Hutch News
Results per Page:
Improving immunotherapy for advanced prostate cancer
Preclinical work identifies better target and recruits more immune cells to make CAR-T therapy work for solid tumors
Classifying prostate cancer subtypes from liquid biopsies
From the Ha and Nelson labs, Human Biology Division
Racial inequalities in prostate cancer treatment among Medicare beneficiaries
From Dr. Yaw Nyame, Fred Hutch Public Health Sciences Division and the University of Washington
New computational tools widen horizons for liquid biopsies
Methods allow scientists to use gene regulation patterns to detect cancer subtype in cell-free DNA
Tracking prostate cancer dynamics
Single-cell study brings prostate tumors into focus and highlights potential treatment target: cancer complexity
Structural landscape of DNA and precision medicine, firm handshake
From the Ha lab, Public Health Sciences and Human Biology Divisions
Identification of potential driver mutations in rare prostate cancer subtype
From the Haffner, Lee, and Ha Labs, Prostate Cancer and Biostatistics and Computational Biology Programs, Cancer Consortium.
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Dr. Anat Zimmer receives AAUW fellowship
Fred Hutch computational biologist who relocated from Israel will receive support while investigating cancer genomics
Dr. Ruth Etzioni receives $7.4M NCI grant to assess new cancer diagnostics
Award will provide long-term support to investigate accuracy of multi-cancer liquid biopsies and other new technology